TMEM217: A Transmembrane Protein Target for Drug Development and Cancer Research

Target Name: TMEM217

NCBI ID: G221468

TMEM217

TMEM217: A Transmembrane Protein Target for Drug Development and Cancer Research

TMEM217 (Transmembrane protein 217, isoform 1) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. It is a member of the transmembrane protein (TMEM) family, which is known for their unique structure and function in various cellular processes. TMEM217 is expressed in various tissues and has been shown to play a role in various cellular processes, including cell signaling, cell adhesion, and tissue repair.

Drug Target Potential

TMEM217 has been identified as a potential drug target due to its unique structure and function. The TMEM217 protein is known to have a transmembrane domain, which is responsible for its unique structure and function. This domain is involved in the formation of the transmembrane region, which is a region of the cell membrane that separates the intracellular and extracellular environments. The transmembrane region is known to be involved in various cellular processes, including cell signaling, cell adhesion, and tissue repair.

TMEM217 has been shown to play a role in several cellular processes, including the regulation of cell signaling, cell adhesion, and tissue repair. For example, TMEM217 has been shown to be involved in the regulation of theNotch signaling pathway, a pathway that is involved in cell signaling and cell adhesion. This is important for the development and maintenance of tissues and organs, as well as for the regulation of various cellular processes.

In addition to its role in cell signaling, TMEM217 has also been shown to play a role in cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. TMEM217 is involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs.

TMEM217 has also been shown to play a role in tissue repair. Tissue repair is a critical process that occurs in the body after injury or disease. TMEM217 is involved in the regulation of tissue repair, which is important for the regulation of cellular processes that support tissue repair.

Biomarker Potential

TMEM217 has also been identified as a potential biomarker for several diseases, including cancer. This is important because TMEM217 can be used as a target for drug development, as well as for the diagnosis and monitoring of cancer.

For example, TMEM217 has been shown to be involved in the regulation of cell signaling, which is important for the development and maintenance of cancer. This is important because changes in cell signaling can contribute to the development and progression of cancer. TMEM217 has also been shown to play a role in the regulation of cell adhesion, which is important for the development and maintenance of cancer. This is important because changes in cell adhesion can contribute to the development and progression of cancer.

In addition to its role in cancer, TMEM217 has also been shown to be involved in the regulation of other cellular processes, including cell signaling and cell adhesion. This is important because changes in these processes can contribute to the development and progression of a wide range of diseases, including cancer.

Conclusion

In conclusion, TMEM217 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function make it an attractive target for drug development, as well as for the diagnosis and monitoring of cancer. Further research is needed to fully understand the role of TMEM217 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Transmembrane Protein 217

The "TMEM217 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM217 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets